Kymera Investments vs Other Non Cash Items Analysis

KYMR Stock  USD 40.66  1.52  3.88%   
Kymera Therapeutics financial indicator trend analysis is infinitely more than just investigating Kymera Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kymera Therapeutics is a good investment. Please check the relationship between Kymera Therapeutics Investments and its Other Non Cash Items accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kymera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Kymera Stock, please use our How to Invest in Kymera Therapeutics guide.

Investments vs Other Non Cash Items

Investments vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kymera Therapeutics Investments account and Other Non Cash Items. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Kymera Therapeutics' Investments and Other Non Cash Items is -0.36. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Kymera Therapeutics, assuming nothing else is changed. The correlation between historical values of Kymera Therapeutics' Investments and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Kymera Therapeutics are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Investments i.e., Kymera Therapeutics' Investments and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

-0.36
Relationship DirectionNegative 
Relationship StrengthInsignificant

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Other Non Cash Items

Most indicators from Kymera Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kymera Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kymera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Kymera Stock, please use our How to Invest in Kymera Therapeutics guide.At this time, Kymera Therapeutics' Sales General And Administrative To Revenue is relatively stable compared to the past year. As of 12/23/2024, Enterprise Value is likely to grow to about 1.9 B, while Selling General Administrative is likely to drop slightly above 30.3 M.
 2021 2022 2023 2024 (projected)
Interest Expense175K176K196K132.7K
Depreciation And Amortization2.4M3.0M3.6M2.3M

Kymera Therapeutics fundamental ratios Correlations

0.660.940.940.990.810.950.570.790.5-0.840.880.540.74-0.570.890.980.550.78-0.20.660.960.960.720.990.67
0.660.740.640.60.540.80.990.380.47-0.910.860.80.840.060.840.550.970.720.131.00.730.680.690.61.0
0.940.740.810.940.610.940.680.540.31-0.920.920.760.65-0.560.950.880.660.92-0.150.740.990.970.630.940.76
0.940.640.810.890.940.870.550.910.65-0.720.850.430.82-0.380.760.930.50.65-0.020.640.850.830.860.890.64
0.990.60.940.890.720.950.520.740.46-0.830.830.490.66-0.650.880.980.510.76-0.350.60.970.980.591.00.62
0.810.540.610.940.720.70.440.960.64-0.560.740.290.83-0.20.560.820.380.470.180.540.660.640.910.720.52
0.950.80.940.870.950.70.740.680.53-0.940.890.60.79-0.460.960.920.740.79-0.280.80.960.960.640.950.82
0.570.990.680.550.520.440.740.280.43-0.880.80.790.790.140.80.460.990.680.140.990.660.610.620.520.99
0.790.380.540.910.740.960.680.280.69-0.460.610.070.74-0.310.50.840.250.34-0.060.380.620.630.760.740.37
0.50.470.310.650.460.640.530.430.69-0.380.510.00.780.230.320.470.470.01-0.180.470.420.440.490.460.46
-0.84-0.91-0.92-0.72-0.83-0.56-0.94-0.88-0.46-0.38-0.9-0.79-0.770.32-0.97-0.76-0.88-0.850.13-0.91-0.91-0.89-0.61-0.83-0.93
0.880.860.920.850.830.740.890.80.610.51-0.90.80.85-0.220.860.790.780.820.110.860.920.890.810.830.86
0.540.80.760.430.490.290.60.790.070.0-0.790.80.5-0.110.740.40.750.870.340.80.690.610.570.490.8
0.740.840.650.820.660.830.790.790.740.78-0.770.850.50.110.680.680.780.470.120.840.690.680.820.660.82
-0.570.06-0.56-0.38-0.65-0.2-0.460.14-0.310.230.32-0.22-0.110.11-0.48-0.650.15-0.540.50.06-0.55-0.58-0.04-0.650.02
0.890.840.950.760.880.560.960.80.50.32-0.970.860.740.68-0.480.830.780.9-0.20.840.940.910.60.880.86
0.980.550.880.930.980.820.920.460.840.47-0.760.790.40.68-0.650.830.430.72-0.270.550.910.920.680.980.57
0.550.970.660.50.510.380.740.990.250.47-0.880.780.750.780.150.780.430.610.040.970.650.610.530.510.98
0.780.720.920.650.760.470.790.680.340.01-0.850.820.870.47-0.540.90.720.610.070.720.860.80.620.760.73
-0.20.13-0.15-0.02-0.350.18-0.280.14-0.06-0.180.130.110.340.120.5-0.2-0.270.040.070.13-0.22-0.310.48-0.350.08
0.661.00.740.640.60.540.80.990.380.47-0.910.860.80.840.060.840.550.970.720.130.730.680.690.61.0
0.960.730.990.850.970.660.960.660.620.42-0.910.920.690.69-0.550.940.910.650.86-0.220.730.990.630.970.75
0.960.680.970.830.980.640.960.610.630.44-0.890.890.610.68-0.580.910.920.610.8-0.310.680.990.560.980.7
0.720.690.630.860.590.910.640.620.760.49-0.610.810.570.82-0.040.60.680.530.620.480.690.630.560.590.66
0.990.60.940.891.00.720.950.520.740.46-0.830.830.490.66-0.650.880.980.510.76-0.350.60.970.980.590.62
0.671.00.760.640.620.520.820.990.370.46-0.930.860.80.820.020.860.570.980.730.081.00.750.70.660.62
Click cells to compare fundamentals

Kymera Therapeutics Account Relationship Matchups

Kymera Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets116.7M487.2M605.9M603.1M575.8M446.0M
Short Long Term Debt Total21.2M18.0M18.0M17.3M84.7M88.9M
Other Current Liab4.6M7.2M19.6M23.9M28.0M15.3M
Total Current Liabilities34.6M110.6M101.0M63.3M85.7M73.3M
Total Stockholder Equity(74.4M)283.9M459.6M490.2M395.0M278.6M
Other Liab29.6M77.9M39.4M28.2M32.5M38.6M
Net Tangible Assets(74.4M)283.9M459.6M490.2M563.7M591.9M
Property Plant And Equipment Net22.1M10.8M11.9M13.3M101.1M106.1M
Current Deferred Revenue23.3M170.4M101.0M63.3M37.9M73.0M
Net Debt(54.8M)(13.0M)(30.0M)(51.1M)(25.3M)(26.6M)
Retained Earnings(76.5M)(128.8M)(229.0M)(383.8M)(530.8M)(504.2M)
Accounts Payable3.3M4.4M4.0M4.3M7.1M4.6M
Cash76.0M31.0M48.0M68.4M110.0M68.7M
Non Current Assets Total23.9M184.8M38.3M43.6M170.4M179.0M
Non Currrent Assets Other1.8M11.5M(98.8M)(122.0M)7.9M8.3M
Other Assets1.8M1.6M8.1M9.1M10.5M11.0M
Cash And Short Term Investments92.0M458.7M567.6M559.5M374.9M383.9M
Net Receivables287K1.4M135K2.5M18.8M19.7M
Common Stock Shares Outstanding44.5M17.3M48.0M53.9M58.4M44.4M
Short Term Investments15.9M265.2M394.4M338.8M264.9M234.5M
Liabilities And Stockholders Equity116.7M487.2M605.9M603.1M575.8M446.0M
Non Current Liabilities Total156.5M92.7M45.2M49.7M95.1M68.4M
Capital Lease Obligations21.2M18.0M18.0M17.3M84.7M88.9M
Other Current Assets888K4.7M8.7M9.7M11.7M6.6M
Other Stockholder Equity(107.0M)412.8M689.3M878.9M926.3M513.5M
Total Liab191.1M203.3M146.3M113.0M180.8M167.4M
Net Invested Capital(74.4M)283.9M459.6M490.2M395.0M278.6M
Property Plant And Equipment Gross22.1M20.7M25.2M29.1M111.5M117.1M
Total Current Assets92.8M302.3M567.6M559.5M405.3M361.1M
Accumulated Other Comprehensive Income6K(128K)(660K)(4.9M)(552K)(579.6K)
Net Working Capital58.3M191.7M358.7M348.1M319.6M240.8M
Short Term Debt3.4M6.5M7.2M7.9M12.7M7.0M
Property Plant Equipment22.1M20.7M11.9M13.3M15.3M15.4M

Pair Trading with Kymera Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kymera Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Kymera Stock

  0.53CDIOW Cardio DiagnosticsPairCorr
  0.46DRTS Alpha Tau MedicalPairCorr
  0.41DMAC DiaMedica Therapeutics Upward RallyPairCorr
The ability to find closely correlated positions to Kymera Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kymera Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kymera Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kymera Therapeutics to buy it.
The correlation of Kymera Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kymera Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kymera Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kymera Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Kymera Stock Analysis

When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.